Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Invitrogen

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 17 April 1998:
Vol. 280. no. 5362, p. 372
DOI: 10.1126/science.280.5362.372
Prev | Table of Contents | Next

News & Comment

HUNGARY:
Bailout for Drug Research Institute

Richard Stone

After the fall of the Iron Curtain, many Eastern European researchers abandoned their labs to find better jobs. Now a U.S. investment company and three partners have acquired a majority stake in a drug research institute in Budapest, Hungary, specializing in drugs for cardiovascular and central nervous system diseases. The companies hope to both develop the institute's own candidate drugs and serve Western drug firms looking for a way to test their products at lower cost.

Read the Full Text

ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)